150 related articles for article (PubMed ID: 31022155)
1. ZTlido--a new lidocaine patch for postherpetic neuralgia.
Med Lett Drugs Ther; 2019 Mar; 61(1568):41-43. PubMed ID: 31022155
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV
Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
[TBL] [Abstract][Full Text] [Related]
3. Lidocaine plasters for postherpetic neuralgia?
BMJ Group
Drug Ther Bull; 2008 Feb; 46(2):14-6. PubMed ID: 18256177
[TBL] [Abstract][Full Text] [Related]
4. Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%.
Kirson NY; Ivanova JI; Birnbaum HG; Wei R; Kantor E; Amy Puenpatom R; Ben-Joseph RH; Summers KH
J Med Econ; 2010; 13(3):472-81. PubMed ID: 20684670
[TBL] [Abstract][Full Text] [Related]
5. Lidocaine patch for treatment of postherpetic neuralgia?
Alper BS; Lewis PR
Am Fam Physician; 2006 Aug; 74(3):378; author reply 381. PubMed ID: 16913155
[No Abstract] [Full Text] [Related]
6. Nonopioid drugs for pain.
Med Lett Drugs Ther; 2022 Mar; 64(1645):33-40. PubMed ID: 35231019
[No Abstract] [Full Text] [Related]
7. Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin.
Kirson NY; Ivanova JI; Birnbaum HG; Wei R; Kantor E; Puenpatom RA; Ben-Joseph RH; Summers KH
J Med Econ; 2010; 13(3):482-91. PubMed ID: 20684669
[TBL] [Abstract][Full Text] [Related]
8. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.
Davies PS; Galer BS
Drugs; 2004; 64(9):937-47. PubMed ID: 15101784
[TBL] [Abstract][Full Text] [Related]
9. Topical lidocaine for the treatment of postherpetic neuralgia.
Khaliq W; Alam S; Puri N
Cochrane Database Syst Rev; 2007 Apr; (2):CD004846. PubMed ID: 17443559
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients.
Bursi R; Piana C; Grevel J; Huntjens D; Boesl I
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):801-814. PubMed ID: 28078530
[TBL] [Abstract][Full Text] [Related]
11. WITHDRAWN: Topical lidocaine for the treatment of postherpetic neuralgia.
Khaliq W; Alam S; Puri NK
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004846. PubMed ID: 24166584
[TBL] [Abstract][Full Text] [Related]
12. Clinical practice. Postherpetic neuralgia.
Johnson RW; Rice AS
N Engl J Med; 2014 Oct; 371(16):1526-33. PubMed ID: 25317872
[No Abstract] [Full Text] [Related]
13. Review of current guidelines on the care of postherpetic neuralgia.
Argoff CE
Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096
[TBL] [Abstract][Full Text] [Related]
14. Management of herpes zoster and postherpetic neuralgia.
Tyring SK
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S136-42. PubMed ID: 18021865
[TBL] [Abstract][Full Text] [Related]
15. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy.
Geha PY; Baliki MN; Chialvo DR; Harden RN; Paice JA; Apkarian AV
Pain; 2007 Mar; 128(1-2):88-100. PubMed ID: 17067740
[TBL] [Abstract][Full Text] [Related]
16. Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia.
Wallace M; Pappagallo M
Expert Rev Neurother; 2011 Jan; 11(1):15-27. PubMed ID: 21158551
[TBL] [Abstract][Full Text] [Related]
17. A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia.
Martini CH; Yassen A; Krebs-Brown A; Passier P; Stoker M; Olofsen E; Dahan A
Eur J Pain; 2013 Nov; 17(10):1491-501. PubMed ID: 23650124
[TBL] [Abstract][Full Text] [Related]
18. New analgesics for neuropathic pain: the lidocaine patch.
Argoff CE
Clin J Pain; 2000 Jun; 16(2 Suppl):S62-6. PubMed ID: 10870742
[TBL] [Abstract][Full Text] [Related]
19. Lidocaine patch 5%.
Comer AM; Lamb HM
Drugs; 2000 Feb; 59(2):245-9; discussion 250-1. PubMed ID: 10730547
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy.
Martini A; Del Balzo G; Schweiger V; Zanzotti M; Picelli A; Parolini M; Chinellato E; Tamburin S; Polati E
Minerva Med; 2018 Oct; 109(5):344-351. PubMed ID: 29856191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
